Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge
Rena D. Astronomo, Maria P. Lemos, Sandeep Narpala, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 22

Showing 22 citing articles:

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B. Gilbert, Yunda Huang, Allan C. deCamp, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1924-1932
Open Access | Times Cited: 75
Broadly neutralizing antibodies against HIV-1 and concepts for application
Henning Gruell, Philipp Schommers
Current Opinion in Virology (2022) Vol. 54, pp. 101211-101211
Closed Access | Times Cited: 28
The initial interplay between HIV and mucosal innate immunity
Valeria Caputo, Martina Libera, Sofia Sisti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition
Kelly E. Seaton, Yunda Huang, Shelly Karuna, et al.
EBioMedicine (2023) Vol. 93, pp. 104590-104590
Open Access | Times Cited: 16
Broadly neutralizing monoclonal antibodies for HIV prevention
Maurine D. Miner, Lawrence Corey, David C. Montefiori
Journal of the International AIDS Society (2021) Vol. 24, Iss. S7
Open Access | Times Cited: 33
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11
Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy
Sarah Dohadwala, Matthew T. Geib, Joseph A. Politch, et al.
Frontiers in Reproductive Health (2024) Vol. 5
Open Access | Times Cited: 3
The impact of sex on HIV immunopathogenesis and therapeutic interventions
Erin Mihealsick, Anna Word, Eileen P. Scully
Journal of Clinical Investigation (2024) Vol. 134, Iss. 18
Open Access | Times Cited: 2
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Shuang Li, Christiane Moog, Tong Zhang, et al.
Chinese Medical Journal (2022)
Open Access | Times Cited: 11
Anticipating HIV viral escape – resistance to active and passive immunization
Carolyn Williamson, Rebecca M. Lynch, Penny L. Moore
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 6, pp. 342-348
Closed Access | Times Cited: 5
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Daniel B. Reeves, Bryan T. Mayer, Allan C. deCamp, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
Heidi Hempel, Nicholas J. Mantis, Christopher D. Heaney, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Immunotherapeutic approaches to HIV cure and remission
Ming Lee, Sarah Fidler, John Frater
Current Opinion in Infectious Diseases (2021) Vol. 35, Iss. 1, pp. 31-41
Open Access | Times Cited: 10
3D human tissue models and microphysiological systems for HIV and related comorbidities
Dwight E. Yin, Amy Palin, Tania Lombo, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 5, pp. 526-543
Closed Access | Times Cited: 2
Leveraging lessons learned from the COVID-19 pandemic for HIV
Thomas Calder, Tina Tong, Dale J. Hu, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 4
The Future of HIV Vaccine Development, Learned Lessons from COVID-19 Pandemic
Yehia I. Mohamed
IntechOpen eBooks (2024)
Open Access
Highly Sensitive Analysis of Cervical Mucosal HIV-1 Infection Using Reporter Viruses Expressing Secreted Nanoluciferase
Dana F Indihar, Jennifer J. Jones, Christina Ochsenbauer, et al.
Methods in molecular biology (2024), pp. 299-323
Closed Access
Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa
Maria P. Lemos, Rena D. Astronomo, Yunda Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Ex vivo challenge models for infectious diseases
Bhavna G. Gordhan, Dale Liebenberg, Gabriella Scarlatti, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 785-804
Closed Access | Times Cited: 1
HIV-1 transmission: modelling and direct visualization in the third dimension
Charles A. Coomer, Sergi Padilla‐Parra
Microscopy (2023) Vol. 72, Iss. 3, pp. 164-177
Open Access
EFFICACY AND SAFETY OF INTRAPERITONEAL INFUSION OF RALTITREXED IN LAPAROSCOPIC RADICAL RESECTION OF RECTAL CANCER
CHENGJIANG XIANG
FARMACIA (2023) Vol. 71, Iss. 3, pp. 526-532
Open Access
Page 1

Scroll to top